• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮康唑诱导的肝损伤后出现的持续性黄疸。

Prolonged jaundice following ketoconazole-induced hepatic injury.

作者信息

Benson G D, Anderson P K, Combes B, Ishak K G

机构信息

Department of Medicine, University of Medicine and Dentistry of New Jersey-Rutgers Medical School, Camden 08103.

出版信息

Dig Dis Sci. 1988 Feb;33(2):240-6. doi: 10.1007/BF01535739.

DOI:10.1007/BF01535739
PMID:3338372
Abstract

Two patients developed prolonged and progressive jaundice associated with ketoconazole-induced hepatic injury although the drug was discontinued before or shortly after the onset of symptoms of hepatic toxicity. One patient, who had been jaundiced for eight weeks and was not improving, showed prompt clinical improvement and progressive resolution of jaundice following therapy with prednisolone. Liver biopsy before therapy showed marked cholestasis in all acinar zones and moderately severe fibrosis in the space of Disse. The other patient, who was less severely jaundiced, showed spontaneous resolution although he remained jaundiced for 11 weeks. Liver biopsy performed three weeks after onset of symptoms showed a moderate degree of cholestasis in acinar zone 3 and collagen deposition about the terminal hepatic venules and within the space of Disse. These cases are reported because of the unique clinical course, documentation of the morphologic features, and experience with corticosteroid therapy.

摘要

两名患者出现了与酮康唑诱导的肝损伤相关的持续性和进行性黄疸,尽管在肝毒性症状出现之前或之后不久就停用了该药物。一名患者黄疸持续了八周且病情没有改善,在接受泼尼松龙治疗后临床症状迅速改善,黄疸逐渐消退。治疗前的肝活检显示所有腺泡区均有明显胆汁淤积,狄氏间隙有中度严重纤维化。另一名患者黄疸程度较轻,尽管黄疸持续了11周,但仍自行消退。症状出现三周后进行的肝活检显示3区腺泡有中度胆汁淤积,肝终末小静脉周围和狄氏间隙内有胶原沉积。报告这些病例是因为其独特的临床病程、形态学特征记录以及皮质类固醇治疗经验。

相似文献

1
Prolonged jaundice following ketoconazole-induced hepatic injury.酮康唑诱导的肝损伤后出现的持续性黄疸。
Dig Dis Sci. 1988 Feb;33(2):240-6. doi: 10.1007/BF01535739.
2
Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases.
J Hepatol. 1986;3(3):399-406. doi: 10.1016/s0168-8278(86)80495-0.
3
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症
Pediatrics. 1973 Jun;51(6):998-1007.
4
[Intrahepatic cholestasis due to N-propyl ajmaline].
Dtsch Med Wochenschr. 1976 Apr 30;101(18):699-703. doi: 10.1055/s-0028-1104163.
5
Hepatic toxicity associated with gold therapy.与金疗法相关的肝毒性。
Ann Intern Med. 1977 Dec;87(6):717-9. doi: 10.7326/0003-4819-87-6-717.
6
Severe intrahepatic cholestasis due to thiabendazole.
Am J Trop Med Hyg. 1974 Jul;23(4):676-8. doi: 10.4269/ajtmh.1974.23.676.
7
Amitriptyline-induced prolonged cholestasis.阿米替林诱发的长期胆汁淤积。
Gastroenterology. 1988 Jan;94(1):200-3. doi: 10.1016/0016-5085(88)90631-2.
8
[Terbinafine-induced cholestatic liver injury].[特比萘芬所致胆汁淤积性肝损伤]
Harefuah. 1997 Jul;133(1-2):11-2, 80-1.
9
Fosinopril-induced prolonged cholestatic jaundice and pruritus: first case report.
Eur J Gastroenterol Hepatol. 2001 Mar;13(3):279-82. doi: 10.1097/00042737-200103000-00011.
10
[Experimental study on cell damage of ischemic liver in obstructive jaundiced rats].[阻塞性黄疸大鼠缺血性肝细胞损伤的实验研究]
Nihon Shokakibyo Gakkai Zasshi. 1991 May;88(5):1200-7.

引用本文的文献

1
Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor.酮康唑对芳烃受体的对映体特异性作用。
PLoS One. 2014 Jul 7;9(7):e101832. doi: 10.1371/journal.pone.0101832. eCollection 2014.
2
Drug-induced liver injury: is it somehow foreseeable?药物性肝损伤:在某种程度上可以预见吗?
World J Gastroenterol. 2009 Jun 21;15(23):2817-33. doi: 10.3748/wjg.15.2817.
3
The treatment of advanced prostate cancer with ketoconazole: safety issues.酮康唑治疗晚期前列腺癌:安全性问题。

本文引用的文献

1
Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin.慢性活动性肝炎及与呋喃妥因相关的严重肝坏死。
Ann Intern Med. 1980 Jan;92(1):14-9. doi: 10.7326/0003-4819-92-1-14.
2
Corticosteroid therapy for chronic active hepatitis.慢性活动性肝炎的皮质类固醇疗法。
Am J Gastroenterol. 1984 Jul;79(7):573-5.
3
Fatal hepatitis associated with ketoconazole therapy.与酮康唑治疗相关的致命性肝炎。
Drug Saf. 1999 May;20(5):451-8. doi: 10.2165/00002018-199920050-00005.
4
Adverse drug reactions to systemic antifungals. Prevention and management.全身性抗真菌药物的药物不良反应。预防与管理。
Drug Saf. 1992 Sep-Oct;7(5):323-63. doi: 10.2165/00002018-199207050-00003.
Arch Intern Med. 1984 May;144(5):1069-70.
4
Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases.酮康唑治疗相关的肝损伤。33例病例分析。
Gastroenterology. 1984 Mar;86(3):503-13.
5
Hepatic toxicity of ketoconazole.酮康唑的肝毒性。
Br J Dermatol. 1983 Mar;108(3):376-8. doi: 10.1111/j.1365-2133.1983.tb03981.x.
6
Toxic hepatis during ketoconazole treatment.酮康唑治疗期间的中毒性肝炎。
Br Med J (Clin Res Ed). 1981 Sep 26;283(6295):825-6. doi: 10.1136/bmj.283.6295.825.
7
Hepatic reactions during ketoconazole treatment.酮康唑治疗期间的肝脏反应。
Am J Med. 1983 Jan 24;74(1B):80-5. doi: 10.1016/0002-9343(83)90519-3.
8
Ketoconazole-induced fulminant hepatitis.酮康唑诱发的暴发性肝炎。
Gut. 1985 Jun;26(6):636-8. doi: 10.1136/gut.26.6.636.
9
Drug-induced chronic liver disease.药物性慢性肝病
Gastroenterology. 1977 Jun;72(6):1348-53.